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NIVELI GJENETIK I PENETRIMIT DHE EKSPRESIVITETIT NË
FAKTORËT PËR HEMOFILIN E TIPIT A, HEMOGLOBINË,
aPTT DHE GJENOTIP
ГЕНЕТСКО НИВО НА ПЕНЕТРАЦИЈА И ЕКСПРЕСИВНОСТА
ВО ФАКТОРИТЕ ЗА ТИПОТ А НА ХЕМОФИЛИЈА,
ХЕМОГЛОБИН, aPTT И ГЕНОТИПОТ
GENETIC LEVEL OF PENETRATION AND EXPRESSIVITY IN
FACTORS FOR TYPE OF HEMOPHILIA, HEMOGLOBIN, aPTT
AND GENOTYPE
Abstract
This study investigates the penetration and genetic expression of
factor VIII of hemophilia to individuals who are in the fourth degree of
kinship from the mother’s line. So it comes to two hemophiliac brothers
and a hemophiliac cousin whose mothers are sisters but who are married
in different families. For these cases of hemophiliacs were performed
laboratory, biochemical and genetic analyzes to observe the level of
penetration and expression of factor VIII. We will present with the help
of the genetic tree the origins or gene genealogies of the gene for this
disease. Based on biochemical and genetic analysis using PCR, we will
present factor I, IX, XI, aTTP, vWF-Factor Von Willebrandov, locus
Xq28, ccddee genotype, fibrinogen, blood group, rhesus factor in hemophiliacs involved in this study. We will likewise compare the laboratory analysis of individuals and look at the similarities or differences in
the values gained. Based on these results, doctors can determine doses
University of Business and Technology (UBT) – Department of Dentistry - Pristina
University of Business and Technology (UBT) – Department of Pharmacy - Pristina

1
2

342

C E N T R U M 11

about these cases with hemophilia. In this case it is suggested that the
heparin dose should be in correlation with the aPTT activity to avoid
thrombin.
Introduction
The work was carried out in the Presevo population stretching
east of Kosovo and south-east of Serbia in the E75 valley. Hemophilia
A is inherited through the X sexual chromosome. Women have 50%
chance of transmitting factor VIII mutation to each pregnancy. The
males who inherit from the mother factor VIII will be affected by
hemophilia. Men with factor VIII transmit mutation to all their daughters and never to their sons. According to genealogy analysis and interviews in families made and related to this case of hemophilia A, we will
parse the track of this gene. With this study we can comment on the
inheritance of hemophilia A through generations and we will see that
this mutation comparing the obtained results has or does not have any
correlation between the individuals in this paper.
Material and methods
The material for this paper is collected in the form of a questionnaire
in the families in Presevo and in the villages around Presevo. During this
questionnaire we have had cases with hemophilia type A, where from 6000
inhabitants we identified 4 cases of male hemophilia A but one of them
died. From the detailed analysis we saw that it is about three first cousins
from the maternal line that are in the genetic vicinity at the 4th degree of
kinship. For this study, we conducted genome genealogical research that
was affected by factor VIII of hemophilia.
Genetic trees have been used as a method by which we can
become familiar with the history or genealogy of hemophilia.
To become familiar with the level of hemophilic factors and to
know their genotype for this disease, laboratory, biochemical and
genetic analyzes have been done at the Nis institute. For molecular
assays we have the results from the PCR with which the genotype for
hemophilia ccddee is located, the location of the hemophilic gene locus
in the sex X chromosome Xq28. The analysis of the aTTP metacondition factors, factor VIII factor, vWF-factor Von Willebrandov and
other analyzes presented in Table 1 were performed.
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Analysis and discussion of results
a) Genealogical analysis of Hemophilus A
Genealogical analysis of cases with hemophilia A in three families shows that the source of this disease is from the female of generation III-8. This is ascertained by the analysis of previous generations
where we have no cases with this disease. The analysis clearly shows
that we have a dead hemophilia that is in the IV-generation and the
ordinal number 10 (IV-10). Of the three cases with hemophilia we have
also the son with hemophilic disease in the V band and with ordinal
number 9 (V-9) and two hemophiliacs in the V band with ordinal
number 11 (V-11) who is dead and the Vlach of the same generation V
with ordinal number 12 (V-12) alive being hemophilic.
From genealogical analysis (Fig.1) it is clear that factor VIII
factor for type A hemophilia is the individual in generation III with
ordinal number 8 (III-8) which is inherited from her mother’s stock
exchange II with ordinal number 3 (II-3). The person of the generation
IV-10 presented as a target with the arrows is a dead man.
According to genealogical cases, this dead brother IV-10 has two
sisters carrying type A hemophilia that are underlined with the arrows
in IV band with ordinal numbers 14 and 15. Both married sisters (14
and 15) in different families have three dead hemophilic boys in V band
with ordinal number 11 (V-11). While two other hemophiliacs are alive
of the V-9 and V-12 generation. These are in the 4th stage of kinship
1/16. If they make a marriage in this family with IV-degree relatives
every 16th born will be hemophiliac.

Figure 1. The genetic tree of hemophilia disease in cats type A-VIII
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b) Biochemical and genetic analysis of hemophiliacs
From the PCR analysis it is found that the factor VIII of
hemophilia A. The results obtained in the case of hemophilic A-VIII
result in the average type of homophiles with these values of 1.5%,
1.7% and 2%.
The hemoglobin level of hemophilia type A-VIII is 10.4, 10.6,
and 10.7.
The time of thromboplastin activation (aPTT) is clearly seen to
be much delayed 71.7s, 68s and 75s.
The prothrombin test specifically evaluates the presence of
factors VII, V, and X, prothrombin and fibrinogen. A prothrombin time
within the 11-15 second interval (dependent on the source of the
thromboplastin used) indicates that the patient has a normal amount of
upper coagulation factors.
With aPTT ratios of 1.5 to 2.5, in the therapeutic range used by
many labs, variable levels of anti-factor Xa heparin have been achieved.
According to this process it turns out that the defect has to do with the
reversible negative link that will lead to decreased heparin and
thromboplastin growth.
These three cases with hemophilia have the Rh-negative blood
group and according to hemophilia analysis there is a correlation with
the negative factor of the genotype dd. We base this on the basis of the
similarities of the rhesus negative genotype dd with the genotype dd of
hemophiliacs. Therefore, we think that these diseases are caused by a
correlation between the genes in the X chromosome and the gene in the
autosomal chromosome number 1.
Table 1. Laboratory, biochemical and genetic results of hemophiliacs
Three cases
with hemophilia

First person
(first brother)

Second person
(second brother)

Third person
(the cousin of the two
brothers)

Type of
hemophilia
Blood group

Hemophilia type A

Hemophilia type A

A, Rh negative

Hemophilia type
A
A, Rh negative

Factor VIII
level

1.7% (preferably 50150%)

1.5% (preferably
50-150%)

2%( preferably
50-150%)

Factor I level

338,5%

338%

339%

A, Rh negative
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Factor IX level

91,5% (66)

91%

91%

Factor XI level

82.8% (117)

83%

83%

Fibrinogen

4% (130-300
mg/dL)
ccddee

4% (130-300 mg/dL)

Genotype

4.01% (130-300
mg/dL)
ccddee

Intron 22

Region Xq28

Region Xq28

Region Xq28

aPTT(Partial
Thromboplasti
n Time)
Leukocytes

71.7s
(preferably 25-35s)

75s
(preferably 25-35s)

16.5

68s
(preferably 2535s)
17

Erythrocytes

4.20

4.18

4.10

Hemoglobin

10.4 (12-15-g/dL)

10.6

10.7

vWF- Factors
Von
Willebrandov

46%

46%

45%

ccddee

17.1

Analyzing the average values in Table 2 it is clear that factor VIII
has a low level compared to the reference value. Therefore, we say that
the type of hemophilia in these 3 cases is the average type because the
average for these is; 1.37% reference is = 1-5% (F VIIIC> 5 iu dLinternational unit-iu).
Table 2. Laboratory status based on the median values investigated
Test
Factor VIII level
Heavy
Average
Easy
Genotype
aPTT (Partial
Thromboplastin
Time)
Hemoglobin

Average
1.37%
<1%(F VIIIC(1 iu dL)
1-5%(F VIIIC> 5 iu dL)
> 5% (F VIIIC>iu dL)
ccddee
71.56-s

Reference range
50-150%
50-150%
50-150%
50.150%
ccddee
25-36-s

Units
%
iu- international unit
iu- international unit
iu- international unit
Dominant
Seconds -s

10.6

g/dL or g/L

vWF- Factors
Von
Willebrandov

46%

12-15 (120150g/L)
50-160%

%

Therefore, we can conclude that the inheritance of these factors
has been done with a high stability because the expression of the genes
has given the same results in these cases. It is thought that factor VIII
346
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interference which results from mutation in intron 22 in Xq28 region of
chromosome X has had the same penetration.
According to the genetic-PCR analysis it is clear that the three
cases of hemophilia A are ccddee. The locus of the gene in the
chromosome has the region on the Xq-28 arm.
Conclusion
Based on the comparison of the hemoglobin factor in the three
cases with Type A hemophilia, it is clear that there is a correlation
between penetration and expression between the hemophilic factor and
the hemoglobin factor. The activation of thromboplastin for baiting is
approximately the same as it appears: aPTT-71.7s (25-35s), 68s (2535s) and 75s (25-35s). According to the E-cadherin contact protein
analysis there is a filamentous deformation which slows thromboplastin
activity. Also, the level of factor VIII in the three cases has a very low
penetration and therefore the expression is lower and thus does not stop
the flow of blood. Vitamin K has a very low level in the cases mentioned. Factor VIII values are as follows: Case 1. Vllau 1.7% but (preferbly 50-150%); Case 2. Vllau 1.5% (Preferably 50-150%) and Case 3.
Conical 2% (Preferably 50-150%).
Resume
a) Based on the analysis of the laboratory results it is concluded
that it comes to type A Hemophilus. From the obtained laboratory and
genetic results, it is seen that the gene penetrance is very much the same
as the factor VIII and the aPTT factor. They belong to the middle
Hemophilus because they have a mean value of <1.37.
b) Other research has shown that the sensitivity of an APTT
reagent to heparin depends on its phospholipid content and the nature
of the activator present. Therefore, we say that in this case we have an
average of these two factors because the penetration and expressiveness
of the genes is such.
c) We can say that the negative resection factor with genotype dd
in autosomal chromosome 1 has an epigenetic effect on the genotype
dd of the X chromosome (ccddee). This means that hemophilia is a
hereditary disease of the correlation type but also epistatic because the
phenotype is not the only result of the sex X chromosome gene.
347
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d) According to genetic-biochemical analysis it is found that
factor VIII results from mutation in intron 22 in Xq28 region of
chromosome X and their genotype is: ccddee. Genealogical analysis of
cases with hemophilia A in three families shows that the source of this
disease is from the female of generation III-8.
e) It is evident that the number of hemophiliacs is constantly
increasing and that the cause is radioactive pollution of the
environment, chemical, physical, biological, etc.
f) According to the average knowledge of hemophilia arise 1:
5000 - 1: 10000 but from 6000 individuals interviewed there are 4 cases
with type A hemophilia.
Therefore, there is an appeal to international hemophilia societies
to have a genetic care and consultation of populations at risk of these
hemophilic factors.
Reviewed by:
Doc dr. Irfan Ahmedi
Doc dr. Natasa Simonovska
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